Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

18 structures for P39748

Entry ID Method Resolution Chain Position Source
1U7B X-ray 188 A B 331-350 PDB
1UL1 X-ray 290 A X/Y/Z 2-380 PDB
3Q8K X-ray 220 A A 2-336 PDB
3Q8L X-ray 232 A A 2-336 PDB
3Q8M X-ray 260 A A/B 2-336 PDB
3UVU X-ray 238 A B 352-370 PDB
5E0V X-ray 207 A C/D 335-350 PDB
5FV7 X-ray 284 A A/B 1-336 PDB
5K97 X-ray 210 A A 2-336 PDB
5KSE X-ray 210 A A 2-336 PDB
5UM9 X-ray 281 A A 2-336 PDB
5ZOD X-ray 190 A A 1-333 PDB
5ZOE X-ray 195 A A 1-333 PDB
5ZOF X-ray 225 A A 1-333 PDB
5ZOG X-ray 230 A A 1-333 PDB
6TNZ EM 405 A H 1-380 PDB
7QO1 EM 440 A Y 1-380 PDB
AF-P39748-F1 Predicted AlphaFoldDB

270 variants for P39748

Variant ID(s) Position Change Description Diseaes Association Provenance
CA6038609
rs761359771
3 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA6038610
rs771890165
4 Q>H No ClinGen
ExAC
gnomAD
CA380865869
rs1285693421
4 Q>R No ClinGen
TOPMed
rs1442954685
CA380865905
7 A>T No ClinGen
gnomAD
rs1371412552
CA380865923
8 K>Q No ClinGen
TOPMed
gnomAD
CA6038612
rs760566909
10 I>T No ClinGen
ExAC
gnomAD
CA380866011
rs1342986873
14 A>D No ClinGen
Ensembl
rs1342986873
CA380866016
14 A>V No ClinGen
Ensembl
CA6038613
rs766377130
16 S>R No ClinGen
ExAC
gnomAD
CA380866105
rs1208658926
19 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA6038614
rs753721269
19 R>W No ClinGen
ExAC
TOPMed
gnomAD
rs904014727
CA222947928
20 E>K No ClinGen
TOPMed
gnomAD
CA380866167
rs1437939126
23 I>S No ClinGen
gnomAD
rs1300125593
CA380866185
24 K>R No ClinGen
gnomAD
CA380866182
rs1300125593
24 K>T No ClinGen
gnomAD
CA6038615
rs759600121
25 S>N No ClinGen
ExAC
gnomAD
rs765213906
CA6038616
26 Y>C No ClinGen
ExAC
gnomAD
rs1379328024
CA380866248
28 G>D No ClinGen
TOPMed
rs752884600
CA6038618
28 G>S No ClinGen
ExAC
gnomAD
CA6038620
rs764353660
29 R>C No ClinGen
ExAC
gnomAD
CA6038621
rs751874785
29 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs751874785
CA380866264
29 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs1032766776
CA222947967
33 I>V No ClinGen
TOPMed
rs899549369
CA222947968
35 A>V No ClinGen
TOPMed
gnomAD
rs781676618
CA6038623
38 S>N No ClinGen
ExAC
gnomAD
rs781676618
CA380866357
38 S>T No ClinGen
ExAC
gnomAD
CA6038624
rs746376478
41 Q>H No ClinGen
ExAC
TOPMed
gnomAD
rs756703191
CA6038625
47 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs140458864
CA6038626
47 R>H No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs140458864
CA6038627
47 R>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA6038628
rs771800022
48 Q>* No ClinGen
ExAC
gnomAD
rs773029413
CA6038629
48 Q>P No ClinGen
ExAC
gnomAD
rs746730684
CA6038630
49 G>A No ClinGen
ExAC
gnomAD
rs1262747985
CA380866431
50 G>E No ClinGen
TOPMed
CA6038632
rs776543195
50 G>R No ClinGen
ExAC
gnomAD
CA6038634
rs765263498
54 Q>K No ClinGen
ExAC
gnomAD
rs1336211233
CA380866467
55 N>K No ClinGen
gnomAD
rs1213942198
CA380866470
56 E>* No ClinGen
gnomAD
rs775415268
CA6038635
59 E>K No ClinGen
ExAC
gnomAD
CA380866497
TCGA novel
rs1591146151
60 T>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
ClinGen
Ensembl
CA380866551
rs1244378964
64 L>M No ClinGen
gnomAD
rs373582072
CA222948035
65 M>V No ClinGen
Ensembl
rs374732129
CA6038638
67 M>I No ClinGen
ESP
ExAC
gnomAD
rs764263966
CA6038637
67 M>V No ClinGen
ExAC
TOPMed
gnomAD
rs1264740445
CA380866633
69 Y>C No ClinGen
TOPMed
gnomAD
CA6038639
rs202006260
70 R>C No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs767759900
CA380866650
70 R>L No ClinGen
ExAC
gnomAD
rs767759900
CA6038640
70 R>P No ClinGen
ExAC
gnomAD
CA6038642
rs756555908
72 I>T No ClinGen
ExAC
gnomAD
rs145709748
COSM3809763
CA6038643
73 R>C Variant assessed as Somatic; impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
NCI-TCGA
gnomAD
rs145287449
CA6038644
73 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1429943372
CA380866695
74 M>V No ClinGen
TOPMed
gnomAD
TCGA novel 76 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs770679611
CA380866840
82 V>L No ClinGen
ExAC
TOPMed
gnomAD
CA6038648
rs770679611
82 V>M No ClinGen
ExAC
TOPMed
gnomAD
rs1272194166
CA380866857
83 Y>F No ClinGen
gnomAD
rs1173072900
CA380866879
84 V>A No ClinGen
gnomAD
rs1292756975
CA380866867
84 V>I No ClinGen
TOPMed
CA380866913
rs1208499576
86 D>E No ClinGen
gnomAD
CA6038651
rs769573710
87 G>C No ClinGen
ExAC
gnomAD
rs1447886863
CA380866920
87 G>D No ClinGen
gnomAD
rs1351558940
CA380866961
90 P>S No ClinGen
TOPMed
rs1424298787
CA380867047
96 E>D No ClinGen
gnomAD
rs774473787
CA6038655
98 A>V No ClinGen
ExAC
gnomAD
CA380867085
rs1417486527
100 R>C No ClinGen
gnomAD
rs1412724264
CA380867100
101 S>T No ClinGen
gnomAD
CA6038656
rs762018999
103 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA380867123
rs1464197025
103 R>W No ClinGen
TOPMed
rs750703675
CA6038658
104 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs767828296
CA6038657
104 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA6038660
rs766728314
105 A>S No ClinGen
ExAC
TOPMed
gnomAD
rs1414916308
CA380867147
105 A>V No ClinGen
gnomAD
CA6038661
rs754406395
107 A>S No ClinGen
ExAC
TOPMed
rs777413094
CA6038663
108 E>A No ClinGen
ExAC
gnomAD
rs371381466
CA6038664
113 Q>* No ClinGen
ESP
ExAC
gnomAD
CA222948262
rs945654836
114 A>S No ClinGen
TOPMed
rs780924065
CA6038666
115 Q>H No ClinGen
ExAC
TOPMed
gnomAD
CA6038665
rs756841522
115 Q>R No ClinGen
ExAC
gnomAD
CA380867286
rs1204886974
116 A>V No ClinGen
gnomAD
rs1284567207
CA380867288
117 A>P No ClinGen
TOPMed
gnomAD
rs1284567207
CA380867289
117 A>S No ClinGen
TOPMed
gnomAD
CA6038670
rs374555458
120 E>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA380867321
rs1310094151
122 E>Q No ClinGen
TOPMed
CA380867328
rs1300262181
123 V>M No ClinGen
TOPMed
rs542212412
CA6038673
129 R>Q No ClinGen
ExAC
gnomAD
rs774384229
CA6038672
129 R>W No ClinGen
ExAC
gnomAD
CA380867375
rs1469471981
130 L>M No ClinGen
gnomAD
rs760889294
CA6038676
131 V>G No ClinGen
ExAC
gnomAD
rs773486731
CA6038675
131 V>L No ClinGen
ExAC
TOPMed
gnomAD
rs1184364525
CA380867391
132 K>N No ClinGen
Ensembl
CA380867397
rs1591146252
133 V>G No ClinGen
Ensembl
CA380867400
rs1435270808
134 T>P No ClinGen
gnomAD
CA380867407
rs766834617
135 K>R No ClinGen
ExAC
gnomAD
CA6038677
rs766834617
135 K>T No ClinGen
ExAC
gnomAD
rs1444627315
CA380867417
136 Q>H No ClinGen
TOPMed
CA380867415
rs1329297011
136 Q>R No ClinGen
TOPMed
CA6038678
CA6038679
rs754318423
138 N>K No ClinGen
ExAC
TOPMed
gnomAD
CA380867431
rs1399468952
138 N>S No ClinGen
gnomAD
CA6038680
rs765890483
139 D>E No ClinGen
ExAC
gnomAD
rs529767500
CA6038681
141 C>* No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs371928542
CA6038682
142 K>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs780645501
CA6038683
143 H>R No ClinGen
ExAC
gnomAD
rs755782253
CA6038685
145 L>Q No ClinGen
ExAC
gnomAD
CA6038686
rs779822359
146 S>T No ClinGen
ExAC
gnomAD
CA222948321
rs1039192806
147 L>H No ClinGen
TOPMed
CA380867502
rs1197593774
149 G>D No ClinGen
gnomAD
CA222948322
rs11541090
151 P>L No ClinGen
Ensembl
rs1437446180
CA380867544
155 A>V No ClinGen
gnomAD
rs768560253
CA6038688
156 P>A No ClinGen
ExAC
TOPMed
gnomAD
rs768560253
CA380867546
156 P>S No ClinGen
ExAC
TOPMed
gnomAD
CA6038689
rs778852873
159 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1591146303
CA380867607
165 A>T No ClinGen
Ensembl
rs760943389
CA6038693
169 A>S No ClinGen
ExAC
gnomAD
CA6038694
rs771315924
171 K>I No ClinGen
ExAC
gnomAD
CA380867656
rs1444127309
173 Y>D No ClinGen
TOPMed
gnomAD
rs532021925
CA6038695
175 A>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs765802805
CA6038697
176 A>V No ClinGen
ExAC
gnomAD
CA380867681
rs1565315707
177 T>A No ClinGen
Ensembl
CA6038698
rs552145732
177 T>N No ClinGen
1000Genomes
ExAC
gnomAD
CA6038699
rs144781972
178 E>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA380867686
rs144781972
178 E>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA380867706
rs1306950248
180 M>I No ClinGen
TOPMed
rs1251959751
CA380867701
180 M>V No ClinGen
gnomAD
CA380867722
rs1197013504
182 C>F No ClinGen
gnomAD
CA6038701
rs749967877
184 T>S No ClinGen
ExAC
TOPMed
gnomAD
CA6038702
rs755763272
186 G>S No ClinGen
ExAC
gnomAD
CA380867753
rs1265253316
187 S>T No ClinGen
gnomAD
CA6038703
rs766070774
189 V>L No ClinGen
ExAC
gnomAD
rs774159619
CA222948374
190 L>P No ClinGen
Ensembl
CA6038704
rs753589075
190 L>V No ClinGen
ExAC
TOPMed
gnomAD
CA380867774
rs754770893
191 M>R No ClinGen
ExAC
TOPMed
gnomAD
CA6038705
rs754770893
191 M>T No ClinGen
ExAC
TOPMed
gnomAD
CA380867780
rs1302549783
192 R>* No ClinGen
TOPMed
CA6038706
rs778764875
192 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1591146365
CA380867786
193 H>P No ClinGen
Ensembl
CA380867789
rs1394726261
193 H>Q No ClinGen
gnomAD
rs1293287618
CA380867804
196 A>T No ClinGen
TOPMed
gnomAD
rs1565315743
CA380867806
196 A>V No ClinGen
Ensembl
CA380867826
rs1419567262
199 A>T No ClinGen
TOPMed
CA380867842
rs1381476547
201 K>R No ClinGen
TOPMed
TCGA novel 201 K>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs777028114
CA6038712
211 R>Q No ClinGen
ExAC
gnomAD
CA380867910
rs1216844828
211 R>W No ClinGen
gnomAD
rs1421604696
CA380867946
214 Q>H No ClinGen
TOPMed
rs1335710891
CA380867940
214 Q>R No ClinGen
gnomAD
CA380867951
rs746170099
215 E>* No ClinGen
ExAC
TOPMed
gnomAD
rs746170099
CA6038713
215 E>K No ClinGen
ExAC
TOPMed
gnomAD
rs1565315766
CA380868003
219 N>K No ClinGen
Ensembl
rs1418929101
CA380868009
220 Q>R No ClinGen
Ensembl
rs770299892
CA6038714
225 D>Y No ClinGen
ExAC
gnomAD
CA380868084
rs1187059096
226 L>V No ClinGen
gnomAD
CA6038715
rs775779348
228 I>L No ClinGen
ExAC
TOPMed
gnomAD
CA6038716
rs775779348
228 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA380868151
rs1565315778
232 S>T No ClinGen
Ensembl
rs764549465
CA6038717
235 C>S No ClinGen
ExAC
gnomAD
rs1426764580
CA380868200
236 E>G No ClinGen
Ensembl
rs772757950
CA6038718
236 E>K No ClinGen
ExAC
gnomAD
CA222948498
rs528371679
238 I>M No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs199499938
CA380868221
239 R>P No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs199499938
CA6038720
239 R>Q Variant assessed as Somatic; 4.62e-05 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA380868219
rs1460589167
239 R>W No ClinGen
TOPMed
gnomAD
rs754683010
CA6038722
244 K>R No ClinGen
ExAC
gnomAD
CA6038726
rs777591250
245 R>L No ClinGen
ExAC
gnomAD
TCGA novel 245 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs200397900
CA6038724
245 R>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA380868263
rs1312132270
246 A>T No ClinGen
TOPMed
CA380868296
rs1415571176
248 D>E Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
TCGA novel 248 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1393063419
CA380868358
253 H>P No ClinGen
gnomAD
CA380868373
rs1356098864
254 K>R No ClinGen
gnomAD
rs757420433
CA6038728
257 E>* No ClinGen
ExAC
TOPMed
gnomAD
rs1318533237
CA380868426
257 E>D No ClinGen
gnomAD
rs757420433
CA222948552
257 E>K No ClinGen
ExAC
TOPMed
gnomAD
rs141868713
CA6038729
259 I>M No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs371695318
CA6038730
260 V>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs775893236
CA6038732
261 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs770209728
CA6038731
261 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
rs749666139
CA6038733
262 R>* No ClinGen
ExAC
gnomAD
CA6038734
rs769159675
262 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA6038735
rs148519764
263 L>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA222948621
rs922082825
264 D>N No ClinGen
TOPMed
rs1179788168
CA380868513
266 N>H No ClinGen
gnomAD
rs760118285
CA6038736
266 N>S No ClinGen
ExAC
gnomAD
CA6038737
rs770414602
267 K>Q No ClinGen
ExAC
gnomAD
CA380868535
rs1160272664
268 Y>D No ClinGen
TOPMed
gnomAD
CA380868534
rs1160272664
268 Y>H No ClinGen
TOPMed
gnomAD
CA380868543
rs1488529887
269 P>A No ClinGen
TOPMed
CA6038738
rs138109450
269 P>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA222948639
rs865811809
271 P>S No ClinGen
Ensembl
rs1315289001
CA380868569
273 N>S No ClinGen
gnomAD
CA6038739
rs759153619
274 W>* No ClinGen
ExAC
TOPMed
gnomAD
rs1447331543
CA380868583
275 L>F No ClinGen
gnomAD
CA222948658
rs748969364
276 H>Y No ClinGen
TOPMed
rs752485852
CA6038741
277 K>E No ClinGen
ExAC
gnomAD
CA6038744
rs557497901
280 H>Q No ClinGen
1000Genomes
ExAC
gnomAD
rs764028854
CA6038743
280 H>Y Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1236422237
CA380868622
281 Q>E No ClinGen
gnomAD
rs1233981826
CA380868631
282 L>F No ClinGen
TOPMed
CA380868646
rs1276617464
284 L>S No ClinGen
TOPMed
rs750436847
CA222948680
286 P>A No ClinGen
TOPMed
gnomAD
TCGA novel 286 P>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA6038747
rs757326491
286 P>R No ClinGen
ExAC
gnomAD
rs1234311718
CA380868667
287 E>V No ClinGen
gnomAD
rs781421590
CA6038748
288 V>A No ClinGen
ExAC
gnomAD
CA222948700
rs369023056
288 V>M No ClinGen
ESP
TOPMed
CA380868676
rs1385555128
289 L>Q No ClinGen
TOPMed
rs186164169
CA6038749
290 D>V No ClinGen
1000Genomes
ExAC
gnomAD
rs1173228789
CA380868696
292 E>V No ClinGen
TOPMed
CA380868715
rs1210118162
295 E>A No ClinGen
gnomAD
rs780164160
CA6038751
297 K>N No ClinGen
ExAC
gnomAD
rs749625547
CA6038752
299 S>N No ClinGen
ExAC
TOPMed
gnomAD
CA6038753
rs188983237
300 E>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA6038754
rs188983237
300 E>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1174021019
CA380868758
301 P>R No ClinGen
gnomAD
TCGA novel 302 N>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA380868793
rs748648821
306 L>V No ClinGen
ExAC
TOPMed
gnomAD
CA6038756
rs772603170
307 I>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1304135383
CA380868817
309 F>L No ClinGen
gnomAD
CA6038758
rs759067341
309 F>V No ClinGen
ExAC
gnomAD
rs1344202031
CA380868827
311 C>S No ClinGen
gnomAD
rs769444109
CA6038759
314 K>E No ClinGen
ExAC
gnomAD
rs199498803
CA6038760
316 F>Y No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA380868875
rs1268047337
317 S>C No ClinGen
TOPMed
rs762754689
CA6038761
318 E>Q No ClinGen
ExAC
gnomAD
rs751470906
COSM929521
CA6038764
320 R>* Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA380868893
rs1565315915
320 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs765400166
CA222948753
321 I>M No ClinGen
TOPMed
CA6038765
rs141650861
321 I>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs202130520
CA6038766
322 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs756180049
CA6038767
322 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA380868917
rs1340359623
324 G>V No ClinGen
TOPMed
CA6038769
rs780263785
325 V>A No ClinGen
ExAC
gnomAD
rs1272223084
CA380868934
327 R>K No ClinGen
TOPMed
TCGA novel 329 S>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 330 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs753991316
CA6038770
331 S>T No ClinGen
ExAC
gnomAD
rs755294689
CA6038771
332 R>C No ClinGen
ExAC
gnomAD
CA6038772
rs371918257
332 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA6038773
rs371918257
332 R>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1398351987
CA380868978
334 G>S No ClinGen
gnomAD
rs772515013
CA6038774
336 T>A No ClinGen
ExAC
gnomAD
CA380869002
rs1179700751
337 Q>H No ClinGen
gnomAD
CA222948798
rs1013335904
337 Q>K Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA6038775
rs758718503
339 R>C No ClinGen
ExAC
TOPMed
gnomAD
COSM1355266
rs573495657
CA6038776
339 R>H Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
NCI-TCGA
gnomAD
CA380869023
rs1410121025
341 D>G No ClinGen
TOPMed
rs1271811640
CA380869031
342 D>G No ClinGen
gnomAD
rs1355597557
CA380869056
345 K>R No ClinGen
TOPMed
rs1255810639
CA380869062
346 V>A No ClinGen
gnomAD
CA6038777
rs542490356
346 V>M No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 348 G>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs150508629
CA6038779
348 G>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA6038780
rs768399301
349 S>L No ClinGen
ExAC
gnomAD
rs774266785
CA6038781
351 S>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1437773582
CA380869099
353 A>P No ClinGen
TOPMed
rs1193025547
CA380869113
355 R>C No ClinGen
gnomAD
rs761723999
CA6038782
355 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA6038783
rs767523831
356 K>Q No ClinGen
ExAC
gnomAD
TCGA novel 356 K>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs773287912
CA6038784
356 K>R No ClinGen
ExAC
gnomAD
rs1803573
CA222948884
357 E>D No ClinGen
Ensembl
TCGA novel 357 E>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs370181656
CA6038785
358 P>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1320250237
CA380869145
360 P>S No ClinGen
gnomAD
CA6038787
rs753989476
362 G>R No ClinGen
ExAC
gnomAD
rs138459213
CA6038788
364 T>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs765464647
CA6038790
368 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA380869231
rs1283187869
373 A>T No ClinGen
gnomAD
rs7931165
CA222948912
376 F>L No ClinGen
Ensembl
CA380869281
rs1356130035
380 K>R No ClinGen
gnomAD

No associated diseases with P39748

5 regional properties for P39748

Type Name Position InterPro Accession
domain XPG, N-terminal 1 - 107 IPR006085
domain XPG-I domain 146 - 233 IPR006086
conserved_site Helix-hairpin-helix motif, class 2 220 - 253 IPR008918
conserved_site XPG conserved site 79 - 93 IPR019974-1
conserved_site XPG conserved site 149 - 163 IPR019974-2

Functions

Description
EC Number
Subcellular Localization
  • [Isoform 1]: Nucleus, nucleolus
  • Nucleus, nucleoplasm
  • Resides mostly in the nucleoli and relocalizes to the nucleoplasm upon DNA damage
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

7 GO annotations of cellular component

Name Definition
chromosome, telomeric region The end of a linear chromosome, required for the integrity and maintenance of the end. A chromosome telomere usually includes a region of telomerase-encoded repeats the length of which rarely exceeds 20 bp each and that permits the formation of a telomeric loop (T-loop). The telomeric repeat region is usually preceded by a sub-telomeric region that is gene-poor but rich in repetitive elements. Some telomeres only consist of the latter part (for eg. D. melanogaster telomeres).
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
mitochondrion A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
nucleolus A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
protein-containing complex A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.

12 GO annotations of molecular function

Name Definition
5'-3' exonuclease activity Catalysis of the hydrolysis of ester linkages within nucleic acids by removing nucleotide residues from the 5' end.
5'-flap endonuclease activity Catalysis of the cleavage of a 5' flap structure in DNA, but not other DNA structures; processes the 5' ends of Okazaki fragments in lagging strand DNA synthesis.
damaged DNA binding Binding to damaged DNA.
DNA binding Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
double-stranded DNA binding Binding to double-stranded DNA.
double-stranded DNA exodeoxyribonuclease activity Catalysis of the sequential cleavage of mononucleotides from a free 5' or 3' terminus of a double-stranded DNA molecule.
endonuclease activity Catalysis of the hydrolysis of ester linkages within nucleic acids by creating internal breaks.
exonuclease activity Catalysis of the hydrolysis of ester linkages within nucleic acids by removing nucleotide residues from the 3' or 5' end.
flap endonuclease activity Catalysis of the cleavage of a flap structure in DNA, but not other DNA structures; processes the ends of Okazaki fragments in lagging strand DNA synthesis.
magnesium ion binding Binding to a magnesium (Mg) ion.
manganese ion binding Binding to a manganese ion (Mn).
RNA-DNA hybrid ribonuclease activity Catalysis of the endonucleolytic cleavage of RNA in RNA-DNA hybrids to 5'-phosphomonoesters.

11 GO annotations of biological process

Name Definition
base-excision repair, gap-filling Repair of the damaged strand by the combined action of an apurinic endouclease that degrades a few bases on the damaged strand and a polymerase that synthesizes a 'patch' in the 5' to 3' direction, using the undamaged strand as a template.
DNA repair The process of restoring DNA after damage. Genomes are subject to damage by chemical and physical agents in the environment (e.g. UV and ionizing radiations, chemical mutagens, fungal and bacterial toxins, etc.) and by free radicals or alkylating agents endogenously generated in metabolism. DNA is also damaged because of errors during its replication. A variety of different DNA repair pathways have been reported that include direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway.
DNA replication The cellular metabolic process in which a cell duplicates one or more molecules of DNA. DNA replication begins when specific sequences, known as origins of replication, are recognized and bound by initiation proteins, and ends when the original DNA molecule has been completely duplicated and the copies topologically separated. The unit of replication usually corresponds to the genome of the cell, an organelle, or a virus. The template for replication can either be an existing DNA molecule or RNA.
DNA replication, removal of RNA primer Removal of the Okazaki RNA primer from the lagging strand of replicating DNA, by a combination of the actions of DNA polymerase, DNA helicase and an endonuclease.
double-strand break repair The repair of double-strand breaks in DNA via homologous and nonhomologous mechanisms to reform a continuous DNA helix.
double-strand break repair via homologous recombination The error-free repair of a double-strand break in DNA in which the broken DNA molecule is repaired using homologous sequences. A strand in the broken DNA searches for a homologous region in an intact chromosome to serve as the template for DNA synthesis. The restoration of two intact DNA molecules results in the exchange, reciprocal or nonreciprocal, of genetic material between the intact DNA molecule and the broken DNA molecule.
memory The activities involved in the mental information processing system that receives (registers), modifies, stores, and retrieves informational stimuli. The main stages involved in the formation and retrieval of memory are encoding (processing of received information by acquisition), storage (building a permanent record of received information as a result of consolidation) and retrieval (calling back the stored information and use it in a suitable way to execute a given task).
nucleic acid phosphodiester bond hydrolysis The nucleic acid metabolic process in which the phosphodiester bonds between nucleotides are cleaved by hydrolysis.
positive regulation of sister chromatid cohesion Any process that activates or increases the frequency, rate or extent of sister chromatid cohesion.
telomere maintenance via semi-conservative replication The process in which telomeric DNA is synthesized semi-conservatively by the conventional replication machinery and telomeric accessory factors as part of cell cycle DNA replication.
UV protection Any process in which an organism or cell protects itself from ultraviolet radiation (UV), which may also result in resistance to repeated exposure to UV.

9 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q58DH8 FEN1 Flap endonuclease 1 Bos taurus (Bovine) PR
Q5ZLN4 FEN1 Flap endonuclease 1 Gallus gallus (Chicken) PR
Q9VRJ0 Gen Flap endonuclease GEN Drosophila melanogaster (Fruit fly) PR
Q9UQ84 EXO1 Exonuclease 1 Homo sapiens (Human) EV
Q5XIP6 Fen1 Flap endonuclease 1 Rattus norvegicus (Rat) PR
Q75LI2 FEN1B Flap endonuclease 1-B Oryza sativa subsp japonica (Rice) PR
Q9SXQ6 FEN1A Flap endonuclease 1-A Oryza sativa subsp japonica (Rice) PR
C5YUK3 FEN1-A Flap endonuclease 1-A Sorghum bicolor (Sorghum) (Sorghum vulgare) PR
Q9M2Z3 SEND1 Single-strand DNA endonuclease 1 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MGIQGLAKLI ADVAPSAIRE NDIKSYFGRK VAIDASMSIY QFLIAVRQGG DVLQNEEGET
70 80 90 100 110 120
TSHLMGMFYR TIRMMENGIK PVYVFDGKPP QLKSGELAKR SERRAEAEKQ LQQAQAAGAE
130 140 150 160 170 180
QEVEKFTKRL VKVTKQHNDE CKHLLSLMGI PYLDAPSEAE ASCAALVKAG KVYAAATEDM
190 200 210 220 230 240
DCLTFGSPVL MRHLTASEAK KLPIQEFHLS RILQELGLNQ EQFVDLCILL GSDYCESIRG
250 260 270 280 290 300
IGPKRAVDLI QKHKSIEEIV RRLDPNKYPV PENWLHKEAH QLFLEPEVLD PESVELKWSE
310 320 330 340 350 360
PNEEELIKFM CGEKQFSEER IRSGVKRLSK SRQGSTQGRL DDFFKVTGSL SSAKRKEPEP
370
KGSTKKKAKT GAAGKFKRGK